The effectiveness of psychological interventions alone, or in combination with phosphodiesterase-5 inhibitors, for the treatment of erectile dysfunction:A systematic review

被引:7
|
作者
Atallah, Sandrine [1 ]
Haydar, Asad [2 ]
Jabbour, Teddy [2 ]
Kfoury, Peter [3 ]
Sader, Georgio [2 ]
机构
[1] Amer Univ Beirut Med Ctr AUBMC, Dept Obstet & Gynecol, Beirut, Lebanon
[2] Univ Balamand, Fac Med, Koura, Lebanon
[3] Amer Univ Beirut, Fac Med, Beirut, Lebanon
关键词
Erectile dysfunction; systematic review; psychological intervention; combined therapy; phosphodiesterase; 5; inhibitors; cognitive behavioural therapy; 4TH INTERNATIONAL CONSULTATION; COGNITIVE-BEHAVIORAL THERAPY; SEX THERAPY; CONSENSUS STATEMENT; ADJUNCT TREATMENT; YOUNG MEN; HEALTH; SILDENAFIL; MEDICINE; PSYCHOTHERAPY;
D O I
10.1080/2090598X.2021.1926763
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To highlight the efficacy of various psychological interventions (PI) when used in combination with, or in place of, phosphodiesterase-5 inhibitors (PDE-5i), as compared to the traditional treatment of men with erectile dysfunction (ED) with PDE-5i alone. Methods: A comprehensive literature review for the years 2005-2020 via MEDLINE and PubMed. We included randomised controlled trials that compared the use of either PDE-5i alone, PI alone or a combination of PDE-5i and PI in the treatment of psychogenic ED. All studies included were performed in adults aged 19-55 years and were written in English. Results: A total of 13 articles, with an overall sample of 597 men, were included in this systematic review. The results show that the combination of PI and PDE-5i was more effective than either PI or PDE-5i alone, on erectile function and long-term sexual satisfaction in men with psychogenic ED. Combined interventions were found to be significantly superior to medical treatment in seven studies and to PI alone in one study. In comparing PI to PDE-5i, two studies found PI to be significantly superior to PDE-51 use. In three other studies, PI was found significantly superior to no treatment at all, although some participants in the control group had taken PDE-5i. Conclusions: The combination of PDE-5i with PI shows real promise for the treatment of psychogenic ED. However, no conclusions could be made about what PI is more promising than the other and larger studies are needed to confirm these initial findings.
引用
收藏
页码:310 / 322
页数:13
相关论文
共 50 条
  • [21] Erectile dysfunction in patients taking psychotropic drugs and treated with phosphodiesterase-5 inhibitors
    Mazzilli, Rossella
    Angeletti, Gloria
    Olana, Soraya
    Delfino, Michele
    Zamponi, Virginia
    Rapinesi, Chiara
    Del Casale, Antonio
    Kotzalidis, Georgios D.
    Elia, Jlenia
    Callovini, Gemma
    Girardi, Paolo
    Mazzilli, Fernando
    [J]. ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2018, 90 (01) : 44 - 48
  • [22] Value of phosphodiesterase 5 inhibitors as a combination therapy for treating erectile dysfunction: A literature review
    Christopher KOwen
    Kareim Khalafalla
    Run Wang
    [J]. Uroprecision., 2024, 2 (01) - 15
  • [23] Safety and efficacy of intraurethral alprostadil in patients with erectile dysfunction refractory to treatment using phosphodiesterase-5 inhibitors
    Garrido Abad, P.
    Sinues Ojas, B.
    Martinez Blazquez, L.
    Conde Caturla, P.
    Fernandez Arjona, M.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2015, 39 (10): : 635 - 640
  • [24] Phosphodiesterase 5 inhibitors for erectile dysfunction
    Setter, SM
    Iltz, JL
    Fincham, JE
    Campbell, RK
    Baker, DE
    [J]. ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1286 - 1295
  • [25] Phosphodiesterase 5 inhibitors and erectile dysfunction
    Sandner, Peter
    Svenstrup, Niels
    Tinel, Hanna
    Haning, Helmut
    Bischoff, Erwin
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (01) : 21 - 33
  • [26] Phosphodiesterase-5 inhibitors use in patients with erectile dysfunction and cardiovascular disease in clinical practice
    Mamedov, M. N.
    Sharvadze, G. G.
    Poddubsky, E. A.
    Ausheva, A. K.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2010, 6 (05) : 691 - 696
  • [27] Phosphodiesterase-5 (PDE-5) Inhibitors and Ototoxicity: A Systematic Review
    Manna, Sayan
    Gray, Mingyang Liu
    Kaul, Vivian F.
    Wanna, George
    [J]. OTOLOGY & NEUROTOLOGY, 2019, 40 (03) : 276 - 283
  • [28] Managing Erectile Dysfunction in Patients With Cardiovascular Diseases: The Efficacy and Safety of Phosphodiesterase-5 Inhibitors
    Cheng, Judy W. M.
    Berhane, Selamawit R.
    [J]. AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2009, 3 (03) : 201 - 211
  • [29] Phosphodiesterase inhibitors in the treatment of erectile dysfunction
    Stief, CG
    [J]. DRUGS OF TODAY, 2000, 36 (2-3): : 93 - 99
  • [30] Phosphodiesterase inhibitors in the treatment of erectile dysfunction
    Truss, MC
    Stief, CG
    [J]. DRUGS OF TODAY, 1998, 34 (09): : 805 - 812